These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 24726376

  • 1. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K, Miyake T, Koike N, Hattori T, Kumakura S, Yamaguchi T, Matsumoto T, Fujita K, Kuroda M, Ito N, Goto H.
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [Abstract] [Full Text] [Related]

  • 2. Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis.
    Tajima K, Miyake T, Koike N, Hattori T, Takahashi H, Matsumoto T, Fujita K, Kuroda M, Ito N, Goto H.
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):636-41. PubMed ID: 26348840
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
    Onlen Y, Tamer C, Oksuz H, Duran N, Altug ME, Yakan S.
    Microbiol Res; 2007 Dec; 162(1):62-8. PubMed ID: 16904302
    [Abstract] [Full Text] [Related]

  • 6. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK, Kowalski RP, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
    McCormick C, Caballero A, Tang A, Balzli C, Song J, O'Callaghan R.
    Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
    Li SA, Liu J, Xiang Y, Wang YJ, Lee WH, Zhang Y.
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3144-50. PubMed ID: 24637683
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
    Yamagishi Y, Hagihara M, Kato H, Hirai J, Nishiyama N, Koizumi Y, Sakanashi D, Suematsu H, Nakai H, Mikamo H.
    Chemotherapy; 2017 Jun; 62(2):105-110. PubMed ID: 27788502
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M, Philbrick A, Wucher B, Reed JN, Tomaras A, Dunman PM, Wozniak RAF.
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB, Tarantino PA, Hobden JA, Hill JM, O'Callaghan RJ, Kaufman HE, Insler MS.
    Refract Corneal Surg; 1992 Jan; 8(1):39-43. PubMed ID: 1554638
    [Abstract] [Full Text] [Related]

  • 17. Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP).
    Marumo K, Komukai D, Hirose M, Nakamura H, Tanaka H, Ugajin K, Nagashima G, Yoshimura A.
    J Infect Chemother; 2013 Apr; 19(2):348-51. PubMed ID: 22872187
    [Abstract] [Full Text] [Related]

  • 18. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y, Suzuki T, Oka N, Zhang Y, Hayashi Y, Hayashi N, Gotoh N, Ohashi Y.
    Invest Ophthalmol Vis Sci; 2014 Jan 09; 55(1):240-6. PubMed ID: 24255043
    [Abstract] [Full Text] [Related]

  • 19. Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.
    McClellan SA, Ekanayaka SA, Li C, Jiang X, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2015 Dec 09; 56(13):8091-100. PubMed ID: 26720461
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.